These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9335080)

  • 1. 5-HT1A receptors in lithium-induced conditioned taste aversion.
    Wegener G; Smith DF; Rosenberg R
    Psychopharmacology (Berl); 1997 Sep; 133(1):51-4. PubMed ID: 9335080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide modulates lithium-induced conditioned taste aversion.
    Wegener G; Volke V; Bandpey Z; Rosenberg R
    Behav Brain Res; 2001 Jan; 118(2):195-200. PubMed ID: 11164517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic lithium treatment enhances the postsynaptic 5-HT1A receptor-mediated 5-HT behavioral syndrome induced by 8-OH-DPAT in rats via catecholaminergic systems.
    Uchitomi Y; Yamawaki S
    Psychopharmacology (Berl); 1993; 112(1):74-9. PubMed ID: 7871012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-HT1A agonist 8-OH-DPAT dose-dependently interferes with the establishment and the expression of lithium-induced conditioned rejection reactions in rats.
    Limebeer CL; Parker LA
    Psychopharmacology (Berl); 2003 Mar; 166(2):120-6. PubMed ID: 12552358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
    Sugimoto Y; Kimura I; Watanabe Y; Yamada J
    Biol Pharm Bull; 2001 Oct; 24(10):1191-4. PubMed ID: 11642331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indirect in vivo 5-HT1A-agonistic effects of the new antidepressant mirtazapine.
    Berendsen HH; Broekkamp CL
    Psychopharmacology (Berl); 1997 Oct; 133(3):275-82. PubMed ID: 9361334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD; Neill J; Kidd EJ; Fozard JR
    Eur J Pharmacol; 1987 Jan; 133(1):47-56. PubMed ID: 2881789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antagonism of the 5-HT1A receptor stimulus in a conditioned taste aversion procedure.
    Berendsen HH; Broekkamp CL
    Eur Neuropsychopharmacol; 1999 Jun; 9(4):345-9. PubMed ID: 10422896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discriminative stimulus properties of indorenate in a conditioned taste aversion paradigm.
    Miranda F; Hong E; Velázquez-Martínez DN
    Pharmacol Biochem Behav; 2001 Mar; 68(3):427-33. PubMed ID: 11325395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid discrimination of the stimulus properties of 5-hydroxytryptamine agonists using conditioned taste aversion.
    Lucki I
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1120-7. PubMed ID: 2974486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin 5-HT1A receptor-mediated hypothermia in mice: absence of spare receptors and rapid induction of tolerance.
    Meller E; Chalfin M; Bohmaker K
    Pharmacol Biochem Behav; 1992 Oct; 43(2):405-11. PubMed ID: 1359573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
    Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The enhancement by lithium of the 5-HT1A mediated serotonin syndrome produced by 8-OH-DPAT in the rat: evidence for a post-synaptic mechanism.
    Goodwin GM; De Souza RJ; Wood AJ; Green AR
    Psychopharmacology (Berl); 1986; 90(4):488-93. PubMed ID: 2949333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agonist properties of pindolol at h5-HT1A receptors coupled to mitogen-activated protein kinase.
    Millan MJ; Newman-Tancredi A; Duqueyroix D; Cussac D
    Eur J Pharmacol; 2001 Jul; 424(1):13-7. PubMed ID: 11470255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of the 5-HT receptor subtype involved in 8-OH-DPAT-induced hyperlocomotion: potential difficulties arising from inadequate pharmacological tools.
    Kalkman HO; Soar J
    Eur J Pharmacol; 1990 Dec; 191(3):383-90. PubMed ID: 2150821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1A-mediated lower lip retraction: effects of 5-HT1A agonists and antagonists.
    Moore NA; Rees G; Sanger G; Perrett L
    Pharmacol Biochem Behav; 1993 Sep; 46(1):141-3. PubMed ID: 8255903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW; Ogilvie J; Houghton AK
    Br J Pharmacol; 1997 Oct; 122(4):631-8. PubMed ID: 9375958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the 5-HT1A receptor involvement in passive avoidance in the rat.
    Misane I; Johansson C; Ogren SO
    Br J Pharmacol; 1998 Oct; 125(3):499-509. PubMed ID: 9806333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced defaecation in rats: role of central 5-HT1A receptors.
    Croci T; Landi M; Bianchetti A; Manara L
    Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.